AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Docefect-RTU 20mg Injection

Prescription Icon
Prescription Required

Marketer

Aureate Healthcare Pvt Ltd

Salt Composition

Docetaxel (20mg)

Overview Docefect-RTU 20mg Injection

Docefect-RTU 20mg Injection, an anticancer agent, treats breast, non-small cell lung, prostate, and head and neck cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe complications. While benefits may take weeks or months to manifest, discontinue use only upon your doctor's advice. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Your doctor might prescribe additional medication to mitigate these. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts, increasing infection risk; regular blood tests monitoring blood cell levels and liver function are essential. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or current medications (especially anti-infectives), as interactions are possible. Concomitant medications should be disclosed. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.

Primary Ingredients of Docefect-RTU 20mg Injection

There is no text provided to rephrase.

Uses of Docefect-RTU 20mg Injection

Cancers of the breast, lung (non-small cell), prostate, and head and neck.

Major Benefits of Docefect-RTU 20mg Injection:

The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Docefect-RTU 20mg Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Docefect-RTU 20mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Docefect-RTU 20mg Injection works:

Docefect-RTU 20mg Injection is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This targeted action inhibits cancer cell growth, ultimately leading to their demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Docefect-RTU 20mg Injection is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Docefect-RTU 20mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary when the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Administration of Docefect-RTU 20mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Docefect-RTU 20mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

For patients with kidney disease, the 20mg Docefect-RTU Injection presents no safety concerns. No dosage modification is advised for this medication.

LiverLiverCAUTION

Patients with liver impairment should use Docefect-RTU 20mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Docefect-RTU 20mg Injection :

NA

Facts to Know About Docefect-RTU 20mg Injection

LabelValue
Type of Compound Taxane-based agents
Potential for Dependence None.
Type of Treatment Cancer therapeutics
Mechanism of Action Microtubule-targeting drugs: Taxane class

FAQs on Docefect-RTU 20mg Injection

Docefect-RTU 20mg Injection can lead to weight increase, often stemming from fluid retention. This retention may manifest as initial foot swelling, potentially progressing to generalized edema. Contact your physician promptly if you experience foot swelling.
Administer Docefect-RTU 20mg Injection under your physician's guidance. Treatment length depends on your specific cancer and individual response, but infusions are typically given every three weeks.
Docefect-RTU 20mg Injection includes alcohol as an ingredient. Consequently, you might experience drowsiness, disorientation, unsteady gait, or sensations akin to intoxication. This can negatively impact your ability to operate vehicles or equipment immediately following administration. Therefore, refrain from alcohol consumption while undergoing Docefect-RTU 20mg Injection treatment to prevent potential harmful interactions.
Docefect-RTU 20mg Injection is a treatment option for breast cancer, specific lung cancers, prostate cancer, stomach cancer, and cancers of the head and neck. Its mechanism of action involves inhibiting cellular growth and proliferation.
Docefect-RTU 20mg Injection is administered intravenously by healthcare professionals in a clinical setting. This liquid medication is typically infused over a 60-minute period, with administrations spaced three weeks apart.
Regular blood work, including complete blood counts and liver function panels, will be required before each administration of Docefect-RTU 20mg Injection, as directed by your physician. These tests monitor blood cell levels and liver health to ensure suitability for treatment. Low white blood cell counts may manifest as fever or infections.
Docefect-RTU 20mg Injection may cause hair loss, a frequently reported adverse reaction. Hair regrowth is typically observed following discontinuation of Docefect-RTU 20mg Injection. Nevertheless, irreversible hair loss can occur in certain individuals. Seek medical advice if you experience hair loss related to this medication.
Administration of Docefect-RTU 20mg Injection can lead to edema (swelling affecting the extremities) and serious allergic responses. Prophylactic corticosteroids (dexamethasone) are provided to all patients for three days, commencing one day before Docefect-RTU 20mg Injection is given, to mitigate these risks. For patients with metastatic castration-resistant prostate cancer, dexamethasone is administered orally at 12, 3, and 1 hour before Docefect-RTU 20mg Injection infusion.
Docefect-RTU 20mg Injection, a taxoid-class antineoplastic agent, inhibits the proliferation and metastasis of cancerous cells.
Docefect-RTU 20mg Injecti...
2,051
MRP 2,380
13% off